Add to ORKGThe non-steroidal anti-oestrogen tamoxifen has a number of gynaecological side-effects. Apart from an increased risk of endometrial carcinoma, recently ovarian cyst formation during tamoxifen has been observed. This induces the problem of whether or not intervention for these cysts is required. In a cross-sectional study of breast cancer patients receiving tamoxifen, patients only developed ovarian cysts if ovaries responded to tamoxifen, as shown by oestradiol production. Ovarian cysts were not likely to develop in women with amenorrhoea > 1 year or following high-dose chemotherapy. (C) 1998 Elsevier Science Ltd. All rights reserved
Background: Excessive and prolonged estrogenic stimulation results in endometrial hyperplasias or en...
Tamoxifen (TAM), an anti-estrogenic synthetic drug, is widely used in the treatment of breast cancer...
Tamoxifen is a nonsteroidal triphenylethylene delivative that has been widely used in the treatment ...
The non-steroidal anti-oestrogen tamoxifen has a number of gynaecological side-effects. Apart from a...
Tamoxifen is a nonsteroidal anti-oestrogen with gynaecological side-effects. Only recently, ovarian ...
Objective: The purpose of this study was to evaluate patient-related parameters that determine ovari...
OBJECTIVE: Our purpose was to investigate the frequency of ovarian cysts in tamoxifen-treated breast...
WOS: 000176196700021PubMed ID: 12094966Objective: To investigate the frequency of ovarian cysts in t...
Adjuvant endocrine therapy is an integral component of care for endocrine-dependent breast cancer. T...
A Case of hyperestradiolemia induced by Tamoxifen was reported. A 37-year old woman presented with r...
Objective To summarise the available evidence on frequency of ovarian cyst development during mammal...
Tamoxifen, a selective estrogen receptor modulator, is widely used as adjunctive therapy for women w...
Benign ovarian cysts have been suggested to influence breast cancer risk. To provide a comprehensive...
5In a case-control study of 1031 epithelial ovarian cancers and 2311 controls conducted in Italy, 56...
Some studies suggest that the clinical parameter “amenorrhea” is insufficient to define the menopaus...
Background: Excessive and prolonged estrogenic stimulation results in endometrial hyperplasias or en...
Tamoxifen (TAM), an anti-estrogenic synthetic drug, is widely used in the treatment of breast cancer...
Tamoxifen is a nonsteroidal triphenylethylene delivative that has been widely used in the treatment ...
The non-steroidal anti-oestrogen tamoxifen has a number of gynaecological side-effects. Apart from a...
Tamoxifen is a nonsteroidal anti-oestrogen with gynaecological side-effects. Only recently, ovarian ...
Objective: The purpose of this study was to evaluate patient-related parameters that determine ovari...
OBJECTIVE: Our purpose was to investigate the frequency of ovarian cysts in tamoxifen-treated breast...
WOS: 000176196700021PubMed ID: 12094966Objective: To investigate the frequency of ovarian cysts in t...
Adjuvant endocrine therapy is an integral component of care for endocrine-dependent breast cancer. T...
A Case of hyperestradiolemia induced by Tamoxifen was reported. A 37-year old woman presented with r...
Objective To summarise the available evidence on frequency of ovarian cyst development during mammal...
Tamoxifen, a selective estrogen receptor modulator, is widely used as adjunctive therapy for women w...
Benign ovarian cysts have been suggested to influence breast cancer risk. To provide a comprehensive...
5In a case-control study of 1031 epithelial ovarian cancers and 2311 controls conducted in Italy, 56...
Some studies suggest that the clinical parameter “amenorrhea” is insufficient to define the menopaus...
Background: Excessive and prolonged estrogenic stimulation results in endometrial hyperplasias or en...
Tamoxifen (TAM), an anti-estrogenic synthetic drug, is widely used in the treatment of breast cancer...
Tamoxifen is a nonsteroidal triphenylethylene delivative that has been widely used in the treatment ...